本页面由Tiger Trade Technology Pte. Ltd.提供服务

Allogene Therapeutics Inc.

1.40
-0.0600-4.11%
盘前:1.410.0100+0.71%04:55 EDT
成交量:431.65万
成交额:609.39万
市值:4.83亿
市盈率:-2.15
高:1.46
开:1.45
低:1.39
收:1.46
52周最高:4.46
52周最低:1.04
股本:3.45亿
流通股本:2.84亿
量比:0.68
换手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
净资产收益率:-42.39%
总资产收益率:-22.08%
市净率:1.11
市盈率(LYR):-1.62

数据加载中...

2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/03/27

重要事件披露

Current report, item 8.01
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/20

重要事件披露

Current report, item 5.02
2019/11/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, item 1.01
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/08/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/07

重要事件披露

Current report, items 2.02 and 9.01
2019/07/30

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/22

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/22

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/01

持股变动声明

Statement of changes in beneficial ownership of securities